Chenguang Biotech Group (300138) — Financial Flexibility Index
Chenguang Biotech Group (300138) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥562.60 Million (operating CF CN¥524.96 Million minus capex CN¥37.63 Million) represents 0% of total liabilities (CN¥4.57 Billion). Check 300138 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chenguang Biotech Group Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Chenguang Biotech Group across 18 annual periods. See 300138 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chenguang Biotech Group (2007–2024)
Year-by-year free cash flow to debt coverage for Chenguang Biotech Group. For the full company profile including market capitalisation, see Chenguang Biotech Group (300138) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | CN¥-73.28 Million | CN¥-222.81 Million | CN¥5.87 Billion | ▲ +80.6% |
| 2023 | -0.06x | CN¥-321.71 Million | CN¥-510.91 Million | CN¥5.01 Billion | ▼ -126.2% |
| 2022 | 0.25x | CN¥910.84 Million | CN¥734.81 Million | CN¥3.71 Billion | ▲ +125.9% |
| 2021 | 0.11x | CN¥344.72 Million | CN¥63.90 Million | CN¥3.17 Billion | ▼ -70.8% |
| 2020 | 0.37x | CN¥966.29 Million | CN¥529.41 Million | CN¥2.59 Billion | ▲ +326.7% |
| 2019 | 0.09x | CN¥241.38 Million | CN¥-24.35 Million | CN¥2.77 Billion | ▲ +69.3% |
| 2018 | 0.05x | CN¥83.35 Million | CN¥-56.18 Million | CN¥1.62 Billion | ▲ +454.2% |
| 2017 | -0.01x | CN¥-18.18 Million | CN¥-145.95 Million | CN¥1.25 Billion | ▲ +93.8% |
| 2016 | -0.23x | CN¥-226.80 Million | CN¥-321.62 Million | CN¥967.46 Million | ▼ -1496.6% |
| 2015 | 0.02x | CN¥9.47 Million | CN¥-64.66 Million | CN¥564.12 Million | ▼ -97.3% |
| 2014 | 0.62x | CN¥309.58 Million | CN¥272.96 Million | CN¥499.69 Million | ▲ +889.6% |
| 2013 | 0.06x | CN¥40.15 Million | CN¥-36.47 Million | CN¥641.26 Million | ▲ +470.7% |
| 2012 | -0.02x | CN¥-7.56 Million | CN¥-142.11 Million | CN¥447.73 Million | ▼ -100.9% |
| 2011 | 1.79x | CN¥263.90 Million | CN¥82.18 Million | CN¥147.16 Million | ▲ +516.1% |
| 2010 | -0.43x | CN¥-93.05 Million | CN¥-190.51 Million | CN¥215.92 Million | ▼ -188.0% |
| 2009 | 0.49x | CN¥94.13 Million | CN¥27.23 Million | CN¥192.17 Million | ▲ +231.1% |
| 2008 | 0.15x | CN¥35.11 Million | CN¥9.06 Million | CN¥237.31 Million | ▲ +228.9% |
| 2007 | -0.11x | CN¥-9.81 Million | CN¥-23.02 Million | CN¥85.49 Million | — |